Volume 10, Number 8—August 2004
Research
Group G Streptococcal Bacteremia in Jerusalem
Ronit Cohen-Poradosu*, Joseph Jaffe*, David Lavi*, Sigal Grisariu-Greenzaid*, Ran Nir-Paz*, Lea Valinsky†, Mary Dan-Goor†, Colin Block*, Bernard Beall‡, and Allon E. Moses*
Table 1
Summary of clinical characteristic of 94 patients with group G streptococcal bacteremia
| Characteristic | No. of patients (%) |
|---|---|
| Age (y) |
|
| <10 |
3 (3.1) |
| 10–50 |
28 (29.8) |
| 51–75 |
42 (44.7) |
| >75 |
21 (22.3) |
| Median (range) |
62 (2–92) |
| Male |
51 (54.2) |
| Median LOHa in days |
10 |
| Underlying disorder |
|
| Diabetes mellitus |
33 (35.1) |
| Malignancy |
33 (35.1) |
| Hypertension |
18 (19.1) |
| No disease |
8 (8.5) |
| Type of infection |
|
| Cellulitis |
56 (59.6) |
| Primary bacteremia |
18 (19.1) |
| Soft-tissue infectionb |
4 (4.3) |
| Bone and joint |
4 (4.3) |
| Endocarditis |
3 (3.1) |
| Respiratory |
3 (3.1) |
| Postpartum |
1 (1.1) |
| Line sepsis |
1 (1.1) |
| Unknown |
4 (4.3) |
| Death rate | 5 (5.3) |
aLOH, length of hospitalization.
bSoft tissue infection, pressure sore attributable to diabetes
